申请人:Yissum Research Development Company of the Hebrew University of Jerusalem
公开号:US07101864B1
公开(公告)日:2006-09-05
The present invention relates to compositions useful for treating or controlling disease states or conditions associated with zinc containing proteinases, especially metalloproteinases. The active ingredient in these compositions is an alpha-oxo- or alpha-thixophosphpnate of formula (I). Out of the phosphonates of formula (I), some are known and others are new. The novel compounds constitute another aspect of the invention.
本发明涉及用于治疗或控制与含锌蛋白酶,特别是金属蛋白酶相关的疾病状态或病况的组合物。这些组合物中的活性成分是具有化学式(I)的α-氧代或α-硫代膦酸酯。在化学式(I)的膦酸酯中,有些是已知的,而另一些是新的。这些新化合物构成了本发明的另一个方面。